Title : Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential.

Pub. Date : 2010 Jul

PMID : 23908775






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rasagiline (Azilect) is a highly selective and potent propargylamine inhibitor of monoamine oxidase (MAO) type B. propargylamine monoamine oxidase B Homo sapiens